Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review

February 2021 | 56 pages | ID: C6304302902EN
GlobalData

Abstracts

Coloplast AS (COLO B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Coloplast A/S (Coloplast) manufactures and sells products and offers services for ostomy care, urology care, continence care, and skin and wound care. Its major products include urisheaths; ostomy bags; urine bags; catheters; anal irrigation systems; sling products; advanced foam dressings and hydrocolloid dressings for protection of skin and pressure injuries; cleansers; moisturizers; skin protectants; anti-fungals; and hand cleansers. The company offers its products under brands including SenSura, SpeediCath, Persiteen, Biatain, Conveen, InterDry, Brava and Comfeel. Coloplast supplies its products through subsidiaries and distributors to hospitals, institutions, wholesalers and retailers in Europe, Africa, South America, Asia, Russia, Australia and North America. Coloplast is headquartered in Humlebaek, Denmark.

Coloplast AS Key Recent Developments

Nov 04,2020: Coloplast acquires tibial nerve stimulation developer Nine Continents
Nov 03,2020: Coloplast acquires Nine Continents Medical
Nov 03,2020: Coloplast - Announcement no. 10/2020 - Full-year financial results 2019/20
Nov 03,2020: Coloplast delivers solid full year results despite the COVID-19 pandemic and expects 7-8% organic growth and 31-32% EBIT margin for 2020/21
Nov 03,2020: Coloplast - Announcement no. 11/2020 – Annual Report 2019/20 & Remuneration Report 2019/20

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

Table of Contents
List of Tables
List of Figures

SECTION 1 - ABOUT THE COMPANY

Coloplast A/S - Key Facts
Coloplast A/S - Key Employees
Coloplast A/S - Key Employee Biographies
Coloplast A/S - Major Products and Services
Coloplast A/S - History
Coloplast A/S - Company Statement
Coloplast A/S - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Coloplast A/S - Business Description
Business Segment: Chronic Care
Overview
Performance
Business Segment: Interventional Urology
Overview
Performance
Business Segment: Wound & Skin Care
Overview
Performance
Geographical Segment: Emerging Markets
Performance
Geographical Segment: European Markets
Target Markets
Performance
Geographical Segment: Other Developed Markets
Target Markets
Performance
R&D Overview
Coloplast A/S - Corporate Strategy
Coloplast A/S - SWOT Analysis
SWOT Analysis - Overview
Coloplast A/S - Strengths
Coloplast A/S - Weaknesses
Coloplast A/S - Opportunities
Coloplast A/S - Threats
Coloplast A/S - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Coloplast A/S, Medical Equipment, Deals By Year, 2015 to YTD 2021
Coloplast A/S, Medical Equipment, Deals By Type, 2015 to YTD 2021
Coloplast A/S, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Nov 04, 2020: Coloplast acquires tibial nerve stimulation developer Nine Continents
Nov 03, 2020: Coloplast - Announcement no. 10/2020 - Full-year financial results 2019/20
Nov 03, 2020: Coloplast delivers solid full year results despite the COVID-19 pandemic and expects 7-8% organic growth and 31-32% EBIT margin for 2020/21
Nov 03, 2020: Coloplast - Announcement no. 11/2020 – Annual Report 2019/20 & Remuneration Report 2019/20
Sep 29, 2020: Coloplast launches new 2025 strategy and provides new long-term financial guidance
Aug 18, 2020: Coloplast reports -2% organic growth in Q3 due to significant negative impact from COVID-19 – and 5% year to date organic growth
Aug 18, 2020: Coloplast strengthens Executive Management
May 06, 2020: Coloplast: Interim Financial Report, H1 2019/20
May 06, 2020: Coloplast continues solid performance in Q2 with 9% organic growth
Feb 21, 2020: Coloplast - Announcement no. 2/2020 - share buyback programme

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Coloplast A/S, Key Facts
Coloplast A/S, Key Employees
Coloplast A/S, Key Employee Biographies
Coloplast A/S, Major Products and Services
Coloplast A/S, History
Coloplast A/S, Other Locations
Coloplast A/S, Subsidiaries
Coloplast A/S, Key Competitors
Coloplast A/S, Ratios based on current share price
Coloplast A/S, Annual Ratios
Coloplast A/S, Annual Ratios (Cont...1)
Coloplast A/S, Annual Ratios (Cont...2)
Coloplast A/S, Interim Ratios
Coloplast A/S, Medical Equipment, Deals By Year, 2015 to YTD 2021
Coloplast A/S, Medical Equipment, Deals By Type, 2015 to YTD 2021
Coloplast A/S, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Coloplast A/S, Performance Chart (2016 - 2020)
Coloplast A/S, Ratio Charts
Coloplast A/S, Medical Equipment, Deals By Year, 2015 to YTD 2021
Coloplast A/S, Medical Equipment, Deals by Type, 2015 to YTD 2021

COMPANIES MENTIONED

ConvaTec Group Plc
Hollister Inc
GN Store Nord AS
Smith & Nephew Plc
CR Bard Inc
Molnlycke Health Care AB
Convatec Japan KK
B. Braun Melsungen AG
The Procter & Gamble Co